Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00921011 · ClinicalTrials.gov registry record
Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 177
- Enrollment target
NCT00921011 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 177 participants.
The verdict
NCT00921011 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
The study hypothesis (or theory) is that monthly loss of iron before menopause may reduce women's risk of hardening of the arteries, or atherosclerosis. This study uses noninvasive, noncontrast magnetic resonance imaging (MRI) of arteries in women entering menopause. This will help to determine if there is a correlation between iron accumulation and hardening of the arteries. In addition, blood levels of hormones will be measured to help show differences due to hormone levels vs. iron accumulation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2009-05 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00921011
The ClinicalTrials.gov registry entry for NCT00921011 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00921011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00921011 about?
NCT00921011 is a clinical study titled "Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis". The study hypothesis (or theory) is that monthly loss of iron before menopause may reduce women's risk of hardening of the arteries, or atherosclerosis. This study uses noninvasive, noncontrast magnetic resonance imaging (MRI) of arteries in women entering menopause. This will help to determine if ...
What is the current status of trial NCT00921011?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2009-05. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT00921011?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.